CAI

Caris Life Sciences, Inc. Common Stock

24.34

USD

+0.30

+1.25%

Sep 11, 15:59 UTC -4

Closed

Pre-Market

24.23

-0.11

-0.43%

Caris Life Sciences, Inc. Common Stock Profile

About

Caris Life Sciences Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring and precision medicine enabling aspects. Caris Life Sciences Inc. is based in Irving, TX.

Info & Links

CEO

David Dean Halbert

Headquarters

750 W JOHN CARPENTER FREEWAY, SUITE 800
IRVING, TX 75039, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

205

Employees

1,846

Caris Life Sciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

6.85B

Enterprise Value

6.55B

Enterprise Value/EBITDA(ttm)

36.39

Price to Earnings Ratio(ttm)

67.61

Price to Sales(ttm)

6.95

Price to Book(mrq)

11.63

Price to Cash(ytd)

15.27

Profitability

Gross Margin(ttm)

69.24%

Operating Margin(ttm)

10.62%

Profit Margin(ttm)

7.59%

Return on Equity(ttm)

18.77%

Return on Invested Capital(ttm)

11.30%

Return on Assets(ttm)

9.34%

Income Statement

Revenue(ttm)

989.61M

Revenue Per Share(ttm)

3.50

Gross Profit(ttm)

689.36M

EBITDA(ttm)³

180.02M

Net Income Available to Common(ttm)

80.67M

Diluted EPS(ttm)

0.36

Share Statistics

Beta (5Y Monthly)

1.10

52-Week Change

-28.54%

S&P 500 52-Week Change

18.73%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

282.60M

Dividend Yield

0.00%

Float⁴

141.30M

% Held by Insiders

50.00%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

793.12M

Total Cash Per Share(mrq)

2.81

Total Debt(mrq)

393.15M

Total Debt/Equity(mrq)

66.44%

Current Ratio(mrq)

5.53%

Quick Ratio(mrq)

4.88%

Book Value Per Share(mrq)

2.09

Cash Flow

Operating Cash Flow Per Share(ytd)

0.22

Free Cash Flow(ytd)

28.94M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CAI